| 0122 |
Intervention Study |
|
|
Closed |
3/31/2005 |
|
1 |
0 |
|
Cancer Control credit increased from 0.5 to 1.0 as of June 1, 2003 |
| 0123 |
Intervention Study |
|
|
Closed |
8/10/2007 |
0 |
1 |
0 |
|
|
| 0215 |
|
|
|
Closed |
10/31/2006 |
|
1 |
|
|
Cancer Control credit increased from 0.5 to 1.0 as of June 1, 2003 |
| 0315 |
|
|
|
Closed |
6/30/2006 |
0 |
1 |
0 |
|
|
| C9781(R) |
Other |
C9781 |
CALGB |
CL |
3/31/2002 |
1 |
0 |
0 |
0 |
|
| EORTC-30987 |
Genitourinary |
EORTC-30987 |
SWOG |
CL |
6/1/2004 |
1 |
|
0 |
0 |
|
| L0127 |
Intervention Study |
E5597 |
|
Active |
|
|
1 |
0.3 |
|
|
| R9811 |
Gastrointestinal |
INT-0157 |
RTOG |
CL |
12/31/2005 |
1 |
0 |
0 |
0 |
|
| RTOG 0229 |
Lung Non-Small Cell |
|
RTOG |
AC |
|
1 |
0 |
0 |
0 |
|
| RTOG 0424 |
Brain |
|
RTOG |
AC |
|
1 |
0 |
0 |
0 |
|
| RTOG 0435 |
Intervention Study |
|
|
Closed |
2/11/2008 |
0 |
1 |
0 |
0 |
|
| RTOG 0517 |
Intervention Study |
|
|
Active |
|
0 |
1 |
0 |
0 |
|
| RTOG 88-17 |
Head and Neck |
INT-0099 |
SWOG |
CL |
12/1/1995 |
1 |
0 |
0 |
0 |
|
| RTOG 89-11 |
Head and Neck |
INT-0113 |
RTOG |
CL |
12/31/1995 |
1 |
0 |
0 |
0 |
|
| RTOG 90-01 |
Gynecologic |
|
RTOG |
CL |
11/1/1997 |
1 |
0 |
0 |
0 |
|
| RTOG 90-03 |
Head and Neck |
|
RTOG |
CL |
8/1/1997 |
1 |
0 |
0 |
0 |
|
| RTOG 90-04 |
Gastrointestinal |
|
RTOG |
CL |
8/7/1995 |
1 |
0 |
0 |
0 |
|
| RTOG 90-18 |
Gastrointestinal |
INT-0116 |
SWOG |
CL |
7/5/1998 |
1.5 |
0 |
0 |
0 |
HIGH PRIORITY |
| RTOG 90-19 |
Genitourinary |
INT-0086 |
SWOG |
CL |
1/1/1997 |
1 |
0 |
0 |
0 |
|
| RTOG 91-01 |
Lung Non-Small Cell |
INT-0125 |
MDA |
CL |
3/21/1997 |
0 |
1 |
0 |
0 |
1.0 CREDIT FOR YEAR ONE; 0.3 Followup Credit FOR EACH ADDITIONAL YEAR. |
| RTOG 91-02 |
Gastrointestinal |
|
RTOG |
CL |
8/7/1995 |
1 |
0 |
0 |
0 |
|
| RTOG 91-03 |
Lung Non-Small Cell |
|
RTOG |
CL |
1/31/1997 |
0 |
0 |
0 |
0 |
|
| RTOG 91-04 |
Brain |
|
RTOG |
CL |
9/30/1995 |
1 |
0 |
0 |
0 |
|
| RTOG 91-05 |
Lung Non-Small Cell |
INT-0115 |
ECOG |
CL |
12/1/1996 |
1.5 |
0 |
0 |
0 |
HIGH PRIORITY |
| RTOG 91-11 |
Head and Neck |
|
RTOG |
CL |
5/31/2000 |
1.5 |
0 |
0 |
0 |
HIGH PRIORITY |
| RTOG 91-12 |
Gynecologic |
INT-0107 |
SWOG |
CL |
12/15/1996 |
1 |
0 |
0 |
0 |
|
| RTOG 91-15 |
Head and Neck |
90-094 |
MDA |
CL |
6/30/1999 |
0 |
1 |
0 |
0 |
1.0 CREDIT FOR YEAR ONE; 0.3 Followup Credit FOR EACH ADDITIONAL YEAR. |
| RTOG 92-02 |
Genitourinary |
|
RTOG |
CL |
4/15/1995 |
1 |
0 |
0 |
0 |
|
| RTOG 92-03 |
Gastrointestinal |
INT-0130 |
NCCTG |
CL |
12/17/1996 |
1.5 |
0 |
0 |
0 |
HIGH PRIORITY |
| RTOG 92-06 |
Other |
|
RTOG |
CL |
3/1/1996 |
1 |
0 |
0 |
0 |
|
| RTOG 92-08 |
Gastrointestinal |
|
RTOG |
CL |
4/30/1996 |
1 |
0 |
0 |
0 |
|
| RTOG 92-09 |
Pancreatic |
|
RTOG |
CL |
3/21/1997 |
1 |
0 |
0 |
0 |
|
| RTOG 92-11 |
Head and Neck |
|
RTOG |
CL |
8/1/1997 |
0 |
0 |
0 |
0 |
|
| RTOG 93-02 |
Melanoma |
|
RTOG |
CL |
7/1/1997 |
1 |
0 |
0 |
0 |
|
| RTOG 93-03 |
Gastrointestinal |
|
RTOG |
CL |
6/12/1995 |
1 |
0 |
0 |
0 |
|
| RTOG 93-04 |
Lung Non-Small Cell |
|
RTOG |
CL |
3/17/1998 |
1 |
0 |
0 |
0 |
|
| RTOG 93-05 |
Brain |
|
RTOG |
CL |
6/30/2000 |
1 |
0 |
0 |
0 |
|
| RTOG 93-08 |
Other |
|
RTOG |
CL |
3/17/1997 |
0 |
0 |
0 |
0 |
|
| RTOG 93-09 |
Lung Non-Small Cell |
INT-0139 |
RTOG |
CL |
3/31/2002 |
1.5 |
0 |
0 |
0 |
HIGH PRIORITY |
| RTOG 93-10 |
Lymphomas |
INT-0143 |
RTOG |
CL |
12/1/1997 |
1 |
0 |
0 |
0 |
SWOG-9310 |
| RTOG 93-11 |
Lung Non-Small Cell |
|
RTOG |
CL |
12/31/2001 |
1 |
0 |
0 |
0 |
|
| RTOG 93-12 |
Lung |
|
RTOG |
CL |
4/1/1996 |
1 |
0 |
0 |
0 |
|
| RTOG 94-01 |
Gastrointestinal |
INT-0147 |
RTOG |
CL |
2/14/1997 |
1 |
0 |
0 |
0 |
CALGB 9483, ECOG R9401 |
| RTOG 94-02 |
Brain |
INT-0149 |
RTOG |
CL |
3/29/2002 |
1 |
0 |
0 |
0 |
|
| RTOG 94-03 |
Gastrointestinal |
INT-0144 |
SWOG |
CL |
8/1/2000 |
1 |
0 |
0 |
0 |
|
| RTOG 94-04 |
Brain |
|
RTOG |
CL |
3/21/1997 |
1 |
0 |
0 |
0 |
|
| RTOG 94-05 |
Head and Neck |
INT-0123 |
RTOG |
CL |
3/1/2002 |
1 |
0 |
0 |
0 |
|
| RTOG 94-06 |
Genitourinary |
|
RTOG |
AC |
|
1 |
0 |
0 |
0 |
|
| RTOG 94-07 |
Intervention Study |
|
|
Closed |
3/17/1998 |
0 |
0.5 |
|
|
|
| RTOG 94-08 |
Genitourinary |
|
RTOG |
CL |
3/31/2002 |
1 |
0 |
0 |
0 |
|
| RTOG 94-10 |
Lung Non-Small Cell |
|
RTOG |
CL |
7/31/1998 |
1 |
0 |
0 |
0 |
|
| RTOG 94-11 |
Brain |
|
RTOG |
CL |
5/31/1995 |
1 |
0 |
0 |
0 |
|
| RTOG 94-12 |
Genitourinary |
|
RTOG |
CL |
4/1/1995 |
0 |
0 |
0 |
0 |
|
| RTOG 94-13 |
Genitourinary |
|
RTOG |
CL |
6/1/1999 |
1 |
0 |
0 |
0 |
|
| RTOG 94-15 |
Gastrointestinal |
INT-0146 |
NCCTG |
CL |
8/31/2001 |
0 |
0 |
0 |
0 |
NO CREDIT STUDY, FUNDED UNDER A SEPARATE MECHANISM |
| RTOG 94-16 |
Lymphomas |
E1493 |
ECOG |
CL |
4/15/1997 |
1 |
0 |
0 |
0 |
|
| RTOG 94-17 |
Brain |
|
RTOG |
CL |
4/25/1997 |
1 |
0 |
0 |
0 |
|
| RTOG 94-18 |
Head and Neck |
|
SWOG |
CL |
9/1/2002 |
0 |
0 |
0 |
0 |
|
| RTOG 95-01 |
Head and Neck |
|
RTOG |
CL |
4/28/2000 |
1 |
0 |
0 |
0 |
|
| RTOG 95-02 |
Brain |
|
RTOG |
CL |
10/28/1997 |
1 |
0 |
0 |
0 |
|
| RTOG 95-05 |
Head and Neck |
|
RTOG |
CL |
6/26/2000 |
0 |
0 |
0 |
0 |
|
| RTOG 95-06 |
Genitourinary |
|
RTOG |
CL |
12/1/1996 |
1 |
0 |
0 |
0 |
|
| RTOG 95-07 |
Brain |
|
RTOG |
CL |
12/25/1996 |
1 |
0 |
0 |
0 |
|
| RTOG 95-08 |
Brain |
|
RTOG |
CL |
6/15/2001 |
1 |
0 |
0 |
0 |
|
| RTOG 95-11 |
Other |
|
CALGB |
AC |
|
0 |
0.5 |
0 |
0 |
|
| RTOG 95-12 |
Head and Neck |
|
RTOG |
CL |
7/22/2003 |
1 |
0 |
0 |
0 |
|
| RTOG 95-13 |
Brain |
|
RTOG |
CL |
4/15/1998 |
1 |
0 |
0 |
0 |
|
| RTOG 95-14 |
Sarcoma |
R9514 |
RTOG |
CL |
2/1/2000 |
1 |
0 |
0 |
0 |
|
| RTOG 95-17 |
Breast |
|
RTOG |
CL |
3/1/2000 |
1 |
0 |
0 |
0 |
|
| RTOG 96-01 |
Genitourinary |
RTOG-96-01 |
RTOG |
CL |
2/28/2003 |
1 |
0 |
0 |
0 |
|
| RTOG 96-02 |
Brain |
|
RTOG |
CL |
3/21/1997 |
1 |
0 |
0 |
0 |
|
| RTOG 96-04 |
Descriptive |
|
|
Closed |
12/9/1998 |
0 |
0.3 |
|
|
|
| RTOG 96-07 |
Intervention Study |
|
|
Closed |
4/30/1999 |
0 |
0.5 |
|
|
|
| RTOG 96-08 |
Genitourinary |
|
RTOG |
CL |
9/23/1998 |
1 |
0 |
0 |
0 |
|
| RTOG 96-09 |
Lung |
|
RTOG |
CL |
3/31/1998 |
1 |
0 |
0 |
0 |
|
| RTOG 96-10 |
Head and Neck |
|
RTOG |
CL |
4/1/1999 |
1 |
0 |
0 |
0 |
|
| RTOG 96-12 |
Gynecologic |
|
RTOG |
CL |
9/8/1998 |
1 |
0 |
0 |
0 |
|
| RTOG 96-13 |
Gynecologic |
|
RTOG |
CL |
9/8/1998 |
1 |
0 |
0 |
0 |
|
| RTOG 96-14 |
Head and Neck |
E4393 |
ECOG |
CL |
10/18/2002 |
0 |
0 |
0 |
0 |
|
| RTOG 96-15 |
Head and Neck |
|
RTOG |
CL |
1/6/2004 |
1 |
0 |
0 |
0 |
NO CC CRD FOR QOL |
| RTOG 96-16 |
Lung Non-Small Cell |
CALGB-9633 |
CALGB |
CL |
1/26/2005 |
1 |
0 |
0 |
0 |
|
| RTOG 97-01 |
Lung Non-Small Cell |
|
RTOG |
CL |
7/23/1999 |
1 |
0.5 |
0 |
0 |
CC CREDIT FOR QOL COMPONENT |
| RTOG 97-02 |
Breast |
CALGB-9343 |
CALGB |
CL |
2/28/1999 |
1 |
0 |
0 |
0 |
|
| RTOG 97-03 |
Head and Neck |
|
RTOG |
CL |
6/1/1999 |
1 |
0 |
0 |
0 |
|
| RTOG 97-04 |
Pancreatic |
R9704 |
RTOG |
CL |
7/26/2002 |
1 |
0 |
0 |
0 |
|
| RTOG 97-05 |
Lung Non-Small Cell |
|
RTOG |
CL |
6/1/1998 |
1 |
0 |
0 |
0 |
|
| RTOG 97-06 |
Genitourinary |
|
RTOG |
CL |
6/1/1999 |
1 |
0 |
0 |
0 |
|
| RTOG 97-07 |
Gynecologic |
|
RTOG |
CL |
12/3/1998 |
1 |
0 |
0 |
0 |
|
| RTOG 97-08 |
Gynecologic |
|
RTOG |
CL |
4/1/1999 |
1 |
0 |
0 |
0 |
|
| RTOG 97-09 |
Intervention Study |
|
|
Closed |
2/1/2000 |
0 |
1 |
|
|
INCLUDES 6 MO FU |
| RTOG 97-10 |
CNS, Pituitary |
|
RTOG |
CL |
11/5/1999 |
1 |
0 |
0 |
0 |
|
| RTOG 97-12 |
Lung |
|
RTOG |
CL |
10/28/2002 |
1 |
0 |
0 |
0 |
|
| RTOG 97-13 |
Intervention Study |
|
|
Closed |
5/6/1998 |
0 |
0.5 |
|
|
|
| RTOG 97-14 |
Intervention Study |
RTOG 97-14 |
|
Closed |
12/31/2002 |
0 |
0.7 |
|
|
|
| RTOG 98-01 |
Lung Non-Small Cell |
|
RTOG |
CL |
3/29/2002 |
0.5 |
0.5 |
0 |
0 |
INCLUDES QOL COMPONENT |
| RTOG 98-02 |
Brain |
RTOG 98-02 |
RTOG |
CL |
6/27/2002 |
1 |
0 |
0 |
0 |
|
| RTOG 98-03 |
Brain |
|
RTOG |
CL |
9/30/2004 |
1 |
0 |
0 |
0 |
|
| RTOG 98-04 |
Breast |
RTOG 98-04 |
RTOG |
CL |
7/14/2006 |
1 |
|
0 |
0 |
|
| RTOG 98-05 |
Genitourinary |
|
RTOG |
CL |
4/28/2000 |
1 |
0 |
0 |
0 |
|
| RTOG 98-06 |
Brain |
|
RTOG |
CL |
8/20/1999 |
1 |
0 |
0 |
0 |
|
| RTOG 98-07 |
Lung Non-Small Cell |
|
RTOG |
CL |
8/8/2000 |
1 |
0 |
0 |
0 |
|
| RTOG 98-09 |
Intervention Study |
|
|
Closed |
3/7/2001 |
0 |
0.8 |
|
|
|
| RTOG 98-10 |
Lung Non-Small Cell |
|
RTOG |
CL |
6/30/2000 |
1 |
0 |
0 |
0 |
|
| RTOG 98-12 |
Pancreatic |
|
RTOG |
CL |
3/1/2000 |
1 |
0 |
0 |
0 |
|
| RTOG 98-13 |
Brain |
RTOG 98-13 |
RTOG |
CL |
3/30/2007 |
1 |
0 |
0 |
0 |
No CC Credit for the QOL - only assessing toxicity differences |
| RTOG 99-01 |
Intervention Study |
|
|
Closed |
9/10/2002 |
0 |
0.8 |
0 |
0 |
|
| RTOG 99-03 |
Head and Neck |
|
RTOG |
CL |
3/31/2004 |
1 |
0.5 |
0 |
0 |
CC credit is for QOL component |
| RTOG 99-04 |
Gastrointestinal |
RTOG 99-04 |
RTOG |
CL |
3/19/2004 |
1 |
|
0 |
0 |
|
| RTOG 99-10 |
Genitourinary |
|
RTOG |
CL |
5/3/2004 |
1 |
|
0 |
0 |
|
| RTOG 99-11 |
Head and Neck |
|
RTOG |
CL |
6/6/2003 |
1 |
0 |
0 |
0 |
|
| RTOG 99-13 |
Intervention Study |
|
< |